Skip to main content

The Number Needed to Treat: Why is it Important in Clinical Medicine and Public Health?

You will often see the NNT mentioned in clinical guidelines; and when different health interventions are being prioritised or assessed for their clinical effectiveness and cost effectiveness. For example, the NNT was used to inform decisions to recommend statins for people with an elevated risk of cardiovascular disease.

The NNT is a measure used to quantify the effectiveness of an intervention or treatment. It is the average number of patients who need to be treated with a particular therapy for one additional patient to benefit.

How is NNT calculated?

In mathematical terms, the NNT = 1/[Absolute Risk Reduction]

Where Absolute Risk Reduction (ARR) = Control Event Rate (CER) - Experimental Event Rate (EER)

Control Event Rate (CER): The rate of an outcome in a control group.

Experimental Event Rate (EER): The rate of an outcome in an experimental group treated with the intervention.

For example, consider a drug that reduces the risk of heart attack from 4% to 2%. The ARR is 2% or 0.02 and the NNT is 50 (1/0.02). Hence, on average, 50 people will need to be treated to prevent one heart attack.

Importance in Clinical Medicine

The NNT is important in clinical medicine because it helps in the evaluation of the efficacy of treatments by offering a direct, patient-centred measure. It is also helpful in clinical decision making as it allows doctors and patients to make makes evidence-based decisions on treatment options. For example, when presented with data on the NNT, patients can consider how useful a medical intervention is for them.

The NNT also helps in the assessment of the balance between potential benefits and harms of treatment; and provides a uniform metric for comparing the effectiveness of different treatments.

Role of NNT in Public Health

The NNT is also important in public health because it provides a metric that can be used at a population level, offering insights into public health strategies; for example, it can help policy makers determine the most efficient use of healthcare resources. When combined with other metrics, the NNT can be a tool in assessing the cost-effectiveness of public health interventions such as preventive measures, screening and vaccination.

For example, the NNT was used by the UK JCVI to decide which population groups should be prioritised for booster Covid-19 vaccinations by considering how many people in different age groups would need to be vaccinated to prevent one hospital admission.

Limitations of NNT

The NNT does have some limitations. For example, it does not account for side effects or adverse reactions to medical interventions. It is also specific to the particular patient populations and settings from which the data to calculate the NNT was derived. For example, many adverse health outcomes are more common in older people. Hence, the NNT is not uniform over the population and will be lower in groups at higher risk such as the elderly.

Conclusions

Understanding NNT is crucial for both individual clinical decisions and broader public health strategies aimed at population health improvement. It provides an intuitive way to understand the practical impacts of treatment and public health interventions; and is a measure that is useful to many groups including policy makers, clinicians, public health specialists and patients.

Comments

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...

UK Covid-19 Inquiry - The Importance of a Strong Primary Healthcare System

In my witness statement for Module 10 of the UK Covid-19 Inquiry, I discuss the pandemic's impact through from the perspectives of  primary care and public health, drawing on my extensive experience as a senior academic at Imperial College London and as a practising GP and NHS Public Health Specialist.  I emphasise that the pandemic disproportionately affected people who were clinically vulnerable, the disabled, ethnic minority communities and those living in deprived areas. The pandemic highlighted how structural inequalities, multigenerational housing, and employment in high-risk frontline roles exacerbated health disparities.  My statement also critiques the weakening of public health infrastructure - particularly for the control of infectious diseases - and the lack of integrated health data systems to identify at-risk groups such as the clinically vulnerable. I also advocated for a more robust preventive healthcare model that prioritises community-based primary care ...

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...